メディア掲載記事

ACT approaches have the possibilities of therapies with reduced safety concerns, a higher therapeutic index, as well as breadth of targets including solid tumours. More details here.

PharmaVOICE article featuring commentary from E.B. McLindon on the increasing complexity of protocol design & the importance of assessing patient & site burden.

Matthew McCarty at ICON establishes a greater unified approach to patient engagement, retention, and compliance through patient-facing technologies.

ICON has acquired a majority shareholding in MeDiNova Research, a site network with research sites in Europe and Africa.

In this Clinical Informatics News article, featuring commentary from ICON's Marie McCarthy, leveraging technology to accelerate study close-out is discussed.

PharmaVOICE presents a podcast featuring ICON expert Marie McCarthy & Chen Admati (Intel), discussing the use of emerging tech to improve the efficiency of R&D.

An Outsourcing Pharma article featuring commentary from EB McLindon & Gretchen Goller, on ICON’s new web-based patient engagement platform.

There has been growing interest among politicians & the public for significant change of the US healthcare system.

A Clinical Trials Arena article on ICON's new patient engagement platform, supporting people interested in participating in clinical trials.

A PME article discussing the challenges of rare disease trials, including those of recruitment and retention unique to rare disease studies.